DE MONTE, CELESTE
 Distribuzione geografica
Continente #
NA - Nord America 1.505
EU - Europa 441
AS - Asia 167
AF - Africa 10
SA - Sud America 8
Totale 2.131
Nazione #
US - Stati Uniti d'America 1.493
IT - Italia 215
DE - Germania 69
IN - India 67
FI - Finlandia 49
CN - Cina 47
SE - Svezia 44
SG - Singapore 42
GB - Regno Unito 21
IE - Irlanda 20
CA - Canada 11
TG - Togo 10
AR - Argentina 8
UA - Ucraina 7
RO - Romania 4
BG - Bulgaria 3
ES - Italia 3
IR - Iran 3
CH - Svizzera 2
ID - Indonesia 2
MY - Malesia 2
TR - Turchia 2
AT - Austria 1
DK - Danimarca 1
FR - Francia 1
KR - Corea 1
MX - Messico 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 2.131
Città #
Fairfield 271
Ashburn 164
Woodbridge 132
Seattle 113
Cambridge 109
Houston 103
Rome 83
Wilmington 76
Ann Arbor 65
Chandler 38
Dearborn 38
San Paolo di Civitate 38
Princeton 31
Plano 28
Grafing 25
Helsinki 23
Beijing 22
Lawrence 21
Bremen 20
Dublin 20
Latina Scalo 20
Millbury 20
New York 20
Singapore 19
San Diego 17
Boston 11
Lomé 10
Des Moines 8
Federal 8
Norwalk 8
Andover 7
Toronto 7
Munich 6
Redwood City 6
Tampa 6
Collecorvino 4
Hefei 4
Ottawa 4
Jacksonville 3
Kunming 3
Mannheim 3
Nanjing 3
Wuhan 3
Barcelona 2
Bühl 2
Capranica 2
Falls Church 2
Fasano 2
Florence 2
Fonte Nuova 2
Jakarta 2
Laurel 2
Nanchang 2
Perugia 2
Phoenix 2
Pontinia 2
Santa Clara 2
Washington 2
Zurich 2
Adiyaman 1
Ancona 1
Bari 1
Berlin 1
Bolzano Vicentino 1
Buffalo 1
Changchun 1
Chieti 1
Chongqing 1
Falkenstein 1
Farindola 1
Germantown 1
Guangzhou 1
Ipoh 1
Isola Della Scala 1
Istanbul 1
Jinan 1
Kashan 1
Kuching 1
La Canada Flintridge 1
Lanzhou 1
Las Vegas 1
Massimeno 1
Mexico City 1
Modena 1
Napoli 1
Nettuno 1
New Delhi 1
Palestrina 1
Provo 1
Riva 1
Santa Caterina Albanese 1
Seoul 1
Sesto Fiorentino 1
Shanghai 1
Shenyang 1
Sofia 1
Taramani 1
Terni 1
Timisoara 1
Venezia 1
Totale 1.693
Nome #
(Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies 122
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents 117
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity 107
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms 104
Geographical characterization by MAE-HPLC and NIR methodologies and carbonic anhydrase inhibition of Saffron components 102
Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties 99
Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives 95
Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma 93
Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives 86
Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii 80
Bladder cancer: Innovative approaches beyond the diagnosis 77
New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies 77
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 71
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: Enzyme and cellular studies. 71
null 70
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 69
Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII 68
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII—A new scaffold for designing isoform-selective inhibitors 68
Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors 66
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms. 65
null 64
Bioactive compounds of Crocus sativus L. and their semisynthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents 64
null 62
Synthesis and Selective Human Monoamine Oxidase B Inhibition of Heterocyclic Hybrids Based on Hydrazine and Thiazole Scaffolds 57
null 54
Synthesis and selective inhibitory activity against human COX-1 of novel 1-(4-substituted-thiazol-2-yl)-3,5-di(hetero)aryl-pyrazoline derivatives. 52
null 50
New thiadiazoline and thiadiazole analogues of K858: antiproliferative activity in a model of prostate carcinoma 31
null 29
Nitric oxide donors and selective carbonic anhydrase inhibitors: A dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis 20
Metal-chelating salens and tetrahydrosalens and N- and O-substituted acesulfame and saccharin derivatives as selective inhibitors of the cancer-related carbonic anhydrases IX and XII 15
Opening new scenarios for human MAO inhibitors 12
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 11
Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer 7
Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme 6
Totale 2.241
Categoria #
all - tutte 5.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020514 0 0 10 25 57 78 88 75 75 60 27 19
2020/2021235 14 21 8 14 5 12 1 10 54 73 20 3
2021/2022349 2 17 37 8 42 6 10 34 20 25 79 69
2022/2023297 56 77 8 33 21 25 7 20 25 7 16 2
2023/2024207 13 26 7 19 16 53 2 23 1 17 9 21
2024/202525 3 14 8 0 0 0 0 0 0 0 0 0
Totale 2.241